Logo
x

Search

Subscribe Now

All Posts by Date

AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ASCEND Study for R/R Chronic Lymphocytic Leukaemia

AstraZeneca Reports Results of Calquence (acalabrutinib) in P-III ASCEND Study for R/R Chronic Lymphocytic Leukaemia

  • May 8, 2019
Roche Reports Results of Ocrevus (ocrelizumab) in Three P-III Studies for Relapsing and Primary Progressive Multiple Sclerosis

Roche Reports Results of Ocrevus (ocrelizumab) in Three P-III Studies for Relapsing and Primary Progressive Multiple Sclerosis

  • May 8, 2019
Sanofi's Dupixent (dupilumab) Receives European Commission Approval for Severe Asthma with Type 2 Inflammation

Sanofi's Dupixent (dupilumab) Receives European Commission Approval for Severe Asthma with Type 2 Inflammation

  • May 8, 2019
AstraZeneca and Daiichi Report Results of Trastuzumab Deruxtecan (DS-8201) in P-II DESTINY-Breast01 Study for Refractory HER2+ Metastatic Breast Cancer

AstraZeneca and Daiichi Report Results of Trastuzumab Deruxtecan (DS-8201) in P-II DESTINY-Breast01 Study for Refractory HER2+ Met...

  • May 8, 2019
FDA Issues an Alert on Medtronic's Pacemaker or Cardiac Resynchronization Therapy Pacemaker for its Premature Battery Depletion

FDA Issues an Alert on Medtronic's Pacemaker or Cardiac Resynchronization Therapy Pacemaker for its Premature Battery Depletion

  • May 8, 2019
Pfizer to Acquire Therachon for the Expansion of its Rare Disease Portfolio

Pfizer to Acquire Therachon for the Expansion of its Rare Disease Portfolio

  • May 8, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.